Mechanisms of the Rapid Effects of Ketamine on Depression and Sleep Disturbances: A Narrative Review

Overview

Journal Front Pharmacol

Date 2021 Dec 31

PMID 34970147

Citations 8

Authors

Bijia Song

Jun-Chao Zhu

Affiliations

Soon will be listed here.

Abstract

Recently, sleep has been recognized as a crucial factor for health and longevity. The daily sleep/wake cycle provides the basis of biorhythm, which controls whole-body homeostasis and homeodynamics. Sleep disturbances can contribute to several physical and psychological disorders, including cardiovascular disease, obesity, depression, and cognitive dysfunction. The clinical use of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine began in the 1970s. Over the years, physicians have used it as a short-acting anesthetic, analgesic, and antidepressant; however, in-depth research has revealed new possible applications for ketamine, such as for treating sleep disturbances and circadian rhythm disorders. The aim of this narrative review is to examine the literature on the mechanistic role of the antidepressant ketamine in affecting sleep disturbance. Additionally, we discuss the pharmacologic and pharmacokinetic mechanisms of ketamine as an antidepressant and the predictive biomarkers for ketamine's effect on sleep and cognitive function.

Citing Articles

Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depression.

Yan R, Marshall T, Khullar A, Nagle T, Knowles J, Malkin M Ther Adv Psychopharmacol. 2024; 14:20451253241231264.

PMID: 38440104 PMC: 10910882. DOI: 10.1177/20451253241231264.

Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities.

Manosso L, Duarte L, Martinello N, Mathia G, Reus G CNS Neurol Disord Drug Targets. 2023; 23(9):1085-1100.

PMID: 37885113 DOI: 10.2174/0118715273254093231020052002.

The effect of obstructive sleep apnea severity on PTSD symptoms during the course of esketamine treatment: a retrospective clinical study.

Titone M, Hunt C, Bismark A, Nokes B, Lee E, Ramanathan D J Clin Sleep Med. 2023; 19(12):2043-2051.

PMID: 37539643 PMC: 10692930. DOI: 10.5664/jcsm.10746.

A systematic review of the efficacy of ketamine for craniofacial pain.

Hoydonckx Y, McKechnie T, Peer M, Englesakis M, Kumar P Can J Pain. 2023; 7(1):2210167.

PMID: 37383673 PMC: 10294769. DOI: 10.1080/24740527.2023.2210167.

Effect of Ketamine on Sleep in Treatment-Resistant Depression: A Systematic Review.

Kwasny A, Wlodarczyk A, Ogonowski D, Cubala W Pharmaceuticals (Basel). 2023; 16(4).

PMID: 37111325 PMC: 10143949. DOI: 10.3390/ph16040568.

References

Yates W, Mitchell J, Rush A, Trivedi M, Wisniewski S, Warden D . Clinical features of depressed outpatients with and without co-occurring general medical conditions in STAR*D. Gen Hosp Psychiatry. 2004; 26(6):421-9. DOI: 10.1016/j.genhosppsych.2004.06.008. View

Wolkove N, ELKholy O, Baltzan M, Palayew M . Sleep and aging: 1. Sleep disorders commonly found in older people. CMAJ. 2007; 176(9):1299-304. PMC: 1852874. DOI: 10.1503/cmaj.060792. View

McCarley R . Neurobiology of REM sleep. Handb Clin Neurol. 2010; 98:151-71. DOI: 10.1016/B978-0-444-52006-7.00010-1. View

Bohnen N, Hu M . Sleep Disturbance as Potential Risk and Progression Factor for Parkinson's Disease. J Parkinsons Dis. 2019; 9(3):603-614. PMC: 6700634. DOI: 10.3233/JPD-191627. View

Peng W, Achariyar T, Li B, Liao Y, Mestre H, Hitomi E . Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease. Neurobiol Dis. 2016; 93:215-25. PMC: 4980916. DOI: 10.1016/j.nbd.2016.05.015. View

Wei Y, Chang L, Hashimoto K . Molecular mechanisms underlying the antidepressant actions of arketamine: beyond the NMDA receptor. Mol Psychiatry. 2021; 27(1):559-573. PMC: 8960399. DOI: 10.1038/s41380-021-01121-1. View

Rohling M, Green P, Allen 3rd L, Iverson G . Depressive symptoms and neurocognitive test scores in patients passing symptom validity tests. Arch Clin Neuropsychol. 2003; 17(3):205-22. View

Duncan Jr W, Ballard E, Zarate C . Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood. Handb Exp Pharmacol. 2017; 253:337-358. PMC: 5866161. DOI: 10.1007/164_2017_51. View

Duncan Jr W, Slonena E, Hejazi N, Brutsche N, Yu K, Park L . Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties. Biol Psychiatry. 2017; 82(5):361-369. PMC: 5546993. DOI: 10.1016/j.biopsych.2017.03.011. View

10.

Rogers J, Morganti J, Bachstetter A, Hudson C, Peters M, Grimmig B . CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J Neurosci. 2011; 31(45):16241-50. PMC: 3236509. DOI: 10.1523/JNEUROSCI.3667-11.2011. View

11.

Pace-Schott E, Spencer R . Age-related changes in the cognitive function of sleep. Prog Brain Res. 2011; 191:75-89. DOI: 10.1016/B978-0-444-53752-2.00012-6. View

12.

Abdallah C, Sanacora G, Duman R, Krystal J . Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics. Annu Rev Med. 2014; 66:509-23. PMC: 4428310. DOI: 10.1146/annurev-med-053013-062946. View

13.

Zimmerman M, Aloia M . A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med. 2007; 2(4):461-71. View

14.

Koffler S, Hampstead B, Irani F, Tinker J, Kiefer R, Rohr P . The neurocognitive effects of 5 day anesthetic ketamine for the treatment of refractory complex regional pain syndrome. Arch Clin Neuropsychol. 2007; 22(6):719-29. DOI: 10.1016/j.acn.2007.05.005. View

15.

Irwin M, Cole S . Reciprocal regulation of the neural and innate immune systems. Nat Rev Immunol. 2011; 11(9):625-32. PMC: 3597082. DOI: 10.1038/nri3042. View

16.

Fredriksson A, Archer T, Alm H, Gordh T, Eriksson P . Neurofunctional deficits and potentiated apoptosis by neonatal NMDA antagonist administration. Behav Brain Res. 2004; 153(2):367-76. DOI: 10.1016/j.bbr.2003.12.026. View

17.

Caspi A, Hariri A, Holmes A, Uher R, Moffitt T . Genetic sensitivity to the environment: the case of the serotonin transporter gene and its implications for studying complex diseases and traits. Am J Psychiatry. 2010; 167(5):509-27. PMC: 2943341. DOI: 10.1176/appi.ajp.2010.09101452. View

18.

Disner S, Beevers C, Haigh E, Beck A . Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci. 2011; 12(8):467-77. DOI: 10.1038/nrn3027. View

19.

Zarei M, Ibarretxe-Bilbao N, Compta Y, Hough M, Junque C, Bargallo N . Cortical thinning is associated with disease stages and dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2013; 84(8):875-81. PMC: 3717586. DOI: 10.1136/jnnp-2012-304126. View

20.

Rasch B, Born J . About sleep's role in memory. Physiol Rev. 2013; 93(2):681-766. PMC: 3768102. DOI: 10.1152/physrev.00032.2012. View